The chemical class termed "9330159F19Rik Inhibitors" encompasses a range of compounds each possessing distinct biochemical properties and mechanisms of action. While these compounds are not directly associated with 9330159F19Rik due to limited scientific data, they are known to modulate various cellular signaling pathways that could indirectly influence the activity of proteins encoded by this gene.
Compounds such as Trametinib and Cobimetinib, which inhibit MEK, play a critical role in the MAPK/ERK signaling pathway. This pathway is vital for regulating cell proliferation, differentiation, and survival. Modulating this pathway could potentially impact the function of proteins similar to those encoded by 9330159F19Rik. Venetoclax, a BCL-2 inhibitor, targets apoptotic pathways, potentially affecting proteins involved in cell survival and death processes.
Tyrosine kinase inhibitors like Crizotinib, Osimertinib, Afatinib, and Alectinib target various receptors such as ALK, MET, ROS1, EGFR, HER2, and HER4. These receptors are integral to pathways controlling cell growth, proliferation, and survival. By inhibiting these receptors, these compounds might indirectly influence the activity of proteins encoded by genes like 9330159F19Rik.
CDK4/6 inhibitors like Ribociclib and Palbociclib affect cell cycle regulation, potentially impacting proteins involved in cell proliferation. Idelalisib, a PI3K inhibitor, and Olaparib, a PARP inhibitor, target pathways crucial for cell survival, proliferation, and DNA repair, respectively.
Sunitinib, as a multi-kinase inhibitor, exhibits a broad spectrum of activity affecting processes like angiogenesis and tumor cell proliferation. These effects on various signaling pathways highlight the potential of these compounds to indirectly modulate the activity of proteins similar to those encoded by 9330159F19Rik.
In summary, the "9330159F19Rik Inhibitors" class represents a broad approach to understanding and modulating cellular signaling pathways. These compounds serve as valuable tools for research into the functional aspects of proteins and their role in various cellular processes. While direct inhibitors of 9330159F19Rik are not specified due to the lack of detailed information on the protein, this class of inhibitors presents a comprehensive method for exploring the modulation of protein activity within complex cellular networks. Their diverse mechanisms of action, from targeting receptor tyrosine kinases to affecting cell cycle regulation, highlight the intricate balance of cellular processes and provide insights into the potential regulation of proteins encoded by genes like 9330159F19Rik.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $114.00 $166.00 $947.00 | 19 | |
MEK inhibitor, potentially affecting the MAPK/ERK signaling pathway. | ||||||
Cobimetinib | 934660-93-2 | sc-507421 | 5 mg | $270.00 | ||
Another MEK inhibitor, potentially influencing cell proliferation and differentiation. | ||||||
ABT-199 | 1257044-40-8 | sc-472284 sc-472284A sc-472284B sc-472284C sc-472284D | 1 mg 5 mg 10 mg 100 mg 3 g | $118.00 $337.00 $520.00 $832.00 $1632.00 | 10 | |
BCL-2 inhibitor, potentially affecting apoptosis pathways. | ||||||
Osimertinib | 1421373-65-0 | sc-507355 | 5 mg | $86.00 | ||
EGFR inhibitor, potentially affecting cell proliferation and apoptosis. | ||||||
Ribociclib | 1211441-98-3 | sc-507367 | 10 mg | $450.00 | ||
CDK4/6 inhibitor, potentially influencing cell cycle regulation. | ||||||
Afatinib | 439081-18-2 | sc-364398 sc-364398A | 5 mg 10 mg | $114.00 $198.00 | 13 | |
Inhibits EGFR, HER2, and HER4 tyrosine kinases, potentially affecting cell growth and survival. | ||||||
CH5424802 | 1256580-46-7 | sc-364461 sc-364461A | 5 mg 50 mg | $191.00 $902.00 | ||
ALK inhibitor, potentially influencing cell proliferation and survival. | ||||||
CAL-101 | 870281-82-6 | sc-364453 | 10 mg | $193.00 | 4 | |
PI3K inhibitor, potentially affecting cell survival and proliferation pathways. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
PARP inhibitor, potentially influencing DNA repair pathways. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
CDK4/6 inhibitor, potentially affecting cell cycle regulation and proliferation. | ||||||